HexarelinUnderstand the science
What a kidney-injury model revealed about cell-death signals
1 numbered sourceSource years 2023
Peptides are short chains of amino acids held together by peptide bonds. Some can activate receptors and change how cells respond to stress. Hexarelin is a synthetic six-residue growth hormone secretagogue, meaning it can stimulate growth hormone release. A study asked whether it changed the response to a temporary loss of blood flow in an experimental kidney injury. [1]
No recent primary study directly testing hexarelin for this kidney question was identified. In the older 2023 study, researchers interrupted blood flow to rat kidneys and then restored it. Some animals had been exposed to hexarelin before the injury. Compared with injured controls, those rats had lower levels of a kidney-function marker and less tissue damage at the study's short follow-up. In a separate experiment, the researchers exposed cultured kidney cells to low oxygen and then restored it. They observed differences in measures of apoptosis, a regulated process of cell death. [1]
The study also used molecular docking, a computer method that predicts whether two molecules might interact. The model suggested a possible interaction with MDM2, a protein involved in regulating the cell-death pathway associated with p53. The authors measured changes in the relevant proteins in both the animal and cell experiments. A predicted fit and a change in protein levels are evidence for investigating a mechanism, while direct binding and the importance of that binding are separate questions. [1]
The rats were exposed before a planned injury. That model differs from an unexpected kidney injury diagnosed after it develops. The results give direct preclinical evidence on cells and rats and leave open whether hexarelin changes kidney outcomes in people. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
